(SRAD) Sportradar - Overview
Sector: Technology | Industry: Software - Application | Exchange: NASDAQ (USA) | Market Cap: 3.856m USD | Total Return: -45% in 12m
Avg Turnover: 35.1M
Qual. Beats: -1
Rev. Trend: 99.4%
Qual. Beats: 0
Warnings
No concerns identified
Tailwinds
No distinct edge detected
Sportradar Group AG (SRAD) is a Switzerland-based global provider of sports data and technology services for the betting and media industries. The company delivers real-time data points, live odds, and streaming services across major international markets, including North America, Europe, and Asia. Its comprehensive suite includes managed betting services, iGaming solutions, and integrity monitoring to detect match-fixing and fraud.
The sports data sector operates on a business model centered on official data rights, where companies pay sports leagues for exclusive access to provide low-latency feeds to bookmakers. As sports betting legalization expands globally, these high-frequency data streams have become essential infrastructure for live, in-game wagering. For a deeper look into these industry dynamics, consider reviewing the detailed financial breakdowns on ValueRay.
Beyond betting, Sportradar provides performance analytics and content solutions for broadcasters and sports organizations. Its technology facilitates automated content distribution and coaching tools, diversifying its revenue streams across professional sports management and digital media platforms.
- Growth in U.S. betting handle drives high-margin revenue through profit-sharing agreements
- Strategic partnerships with major sports leagues secure exclusive data rights and distribution
- Expansion of managed trading services improves operational margins for global sportsbook operators
- Rising costs for sports data rights pressure long-term EBITDA margin expansion targets
- Shift toward live in-game betting increases demand for real-time data and streaming services
| Net Income: 69.7m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.30 > 1.0 |
| NWC/Revenue: 2.59% < 20% (prev 13.21%; Δ -10.62% < -1%) |
| CFO/TA 0.15 > 3% & CFO 410.0m > Net Income 69.7m |
| Net Debt (-260.4m) to EBITDA (365.2m): -0.71 < 3 |
| Current Ratio: 1.06 > 1.5 & < 3 |
| Outstanding Shares: last quarter (297.6m) vs 12m ago -7.23% < -2% |
| Gross Margin: 38.21% > 18% (prev 0.57%; Δ 3.76k% > 0.5%) |
| Asset Turnover: 50.12% > 50% (prev 45.30%; Δ 4.81% > 0%) |
| Interest Coverage Ratio: 2.02 > 6 (EBITDA TTM 365.2m / Interest Expense TTM 89.2m) |
| A: 0.01 (Total Current Assets 638.2m - Total Current Liabilities 603.7m) / Total Assets 2.75b |
| B: 0.12 (Retained Earnings 317.5m / Total Assets 2.75b) |
| C: 0.07 (EBIT TTM 180.2m / Avg Total Assets 2.65b) |
| D: 0.19 (Book Value of Equity 345.1m / Total Liabilities 1.86b) |
| Altman-Z'' = 1.11 = BB |
| DSRI: 1.01 (Receivables 229.6m/197.7m, Revenue 1.33b/1.15b) |
| GMI: 1.48 (GM 38.21% / 56.61%) |
| AQI: 1.00 (AQ_t 0.74 / AQ_t-1 0.74) |
| SGI: 1.15 (Revenue 1.33b / 1.15b) |
| TATA: -0.12 (NI 69.7m - CFO 410.0m) / TA 2.75b) |
| Beneish M = -2.60 (Cap -4..+1) = A |
As of May 31, 2026, the stock is trading at USD 13.21 with a total of 1,916,371 shares traded.
Over the past week, the price has changed by +1.62%,
over one month by +4.68%,
over three months by -27.66% and
over the past year by -44.96%.
Sportradar has received a consensus analysts rating of 4.53. Therefore, it is recommended to buy SRAD.
- StrongBuy: 10
- Buy: 3
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 21.2 | 60.6% |
Market Cap EUR = 3.31b (3.86b USD * 0.8577 USD.EUR)
P/E Trailing = 50.1154
P/E Forward = 30.9598
P/S = 2.9098
P/B = 3.6918
Revenue TTM = 1.33b EUR
EBIT TTM = 180.2m EUR
EBITDA TTM = 365.2m EUR
Long Term Debt = 50.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 10.9m EUR (from shortTermDebt, last quarter)
Debt = 61.7m EUR (from shortLongTermDebtTotal, last quarter) (leases 62.9m already included)
Net Debt = -260.4m EUR (calculated: Debt 61.7m - CCE 322.1m)
Enterprise Value = 3.05b EUR (3.31b + Debt 61.7m - CCE 322.1m)
Interest Coverage Ratio = 2.02 (Ebit TTM 180.2m / Interest Expense TTM 89.2m)
EV/FCF = 13.03x (Enterprise Value 3.05b / FCF TTM 233.9m)
FCF Yield = 7.68% (FCF TTM 233.9m / Enterprise Value 3.05b)
FCF Margin = 17.62% (FCF TTM 233.9m / Revenue TTM 1.33b)
Net Margin = 5.25% (Net Income TTM 69.7m / Revenue TTM 1.33b)
Gross Margin = 38.21% ((Revenue TTM 1.33b - Cost of Revenue TTM 820.2m) / Revenue TTM)
Gross Margin QoQ = 16.41% (prev 23.83%)
Tobins Q-Ratio = 1.11 (Enterprise Value 3.05b / Total Assets 2.75b)
Interest Expense / Debt = 144.6% (Interest Expense 89.2m / Debt 61.7m)
Taxrate = 15.53% (17.7m / 114.1m)
NOPAT = 152.2m (EBIT 180.2m * (1 - 15.53%))
Current Ratio = 1.06 (Total Current Assets 638.2m / Total Current Liabilities 603.7m)
Debt / Equity = 0.07 (Debt 61.7m / totalStockholderEquity, last quarter 899.1m)
Debt / EBITDA = -0.71 (Net Debt -260.4m / EBITDA 365.2m)
Debt / FCF = -1.11 (Net Debt -260.4m / FCF TTM 233.9m)
Total Stockholder Equity = 953.5m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.63% (Net Income 69.7m / Total Assets 2.75b)
RoE = 7.31% (Net Income TTM 69.7m / Total Stockholder Equity 953.5m)
RoCE = 17.95% (EBIT 180.2m / Capital Employed (Equity 953.5m + L.T.Debt 50.7m))
RoIC = 7.48% (NOPAT 152.2m / Invested Capital 2.04b)
WACC = 7.37% (E(3.31b)/V(3.37b) * Re(7.51%) + (debt cost/tax rate unavailable))
Discount Rate = 7.51% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 42.22 | Cagr: 10.37%
[DCF] Terminal Value 77.97% ; FCFF base≈203.3m ; Y1≈233.0m ; Y5≈342.9m
[DCF] Fair Price = 24.93 (EV 5.16b - Net Debt -260.4m = Equity 5.42b / Shares 217.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.09 | # QB: -1
Revenue Correlation: 99.40 | Revenue CAGR: 20.64% | SUE: -0.48 | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.07 | Chg30d=-12.50% | Revisions=-33% | Analysts=3
EPS next Quarter (2026-09-30): EPS=0.18 | Chg30d=+7.98% | Revisions=+33% | Analysts=3
EPS current Year (2026-12-31): EPS=0.44 | Chg30d=-12.00% | Revisions=-43% | GrowthEPS=+16.8% | GrowthRev=+20.8%
EPS next Year (2027-12-31): EPS=0.75 | Chg30d=+1.36% | Revisions=+14% | GrowthEPS=+69.7% | GrowthRev=+14.2%
[Analyst] Revisions Ratio: -43%